Insomnia is one of the most common complaints among people with schizophrenia. In surveys, more than half report ongoing trouble falling or staying asleep. Unlike in the general population, where insomnia is often a quality-of-life issue, in schizophrenia it carries higher stakes: poor sleep tracks closely with relapse, cognitive decline, and worsening of both positive and negative symptoms. Treating it well is part of treating the illness.
Treating insomnia in schizophrenia starts with sleep hygiene and CBT for insomnia, considers sedating antipsychotic timing or switching, and uses sleep medications selectively — with a strong preference for non-benzodiazepine options.
Why insomnia is different in schizophrenia
Several mechanisms converge:
- Biological sleep changes. Reduced slow-wave sleep, fewer sleep spindles, and altered REM are part of the disorder itself (see sleep architecture in schizophrenia).
- Activation from antipsychotics. Some agents — aripiprazole, lurasidone, ziprasidone in some patients — can be activating and worsen sleep latency.
- Positive symptoms. Voices and paranoia are often worse at night.
- Disrupted circadian rhythms. Less daytime light exposure, less daytime activity, and irregular sleep windows all shift the body clock.
- Co-occurring substances. Caffeine, nicotine, and alcohol are common in this population and all affect sleep.
Step 1: Behavioural foundations
Before any pharmacological intervention, the behavioural foundation matters. Even people who eventually need medication do better with these in place:
- Consistent wake time, even on weekends, within a 30-minute window. This is the strongest behavioural lever for the body clock.
- Morning bright light, ideally outdoors for 20–30 minutes within an hour of waking.
- Limit late caffeine — none after early afternoon for most people. People with schizophrenia metabolise caffeine quickly because of smoking-induced CYP1A2 activity, but cumulative load still matters.
- Wind-down routine for 30–60 minutes before bed, with reduced screen use and dimmed lights.
- Bedroom for sleep only — no TV, work, or scrolling in bed.
See sleep hygiene in schizophrenia for a more detailed walkthrough.
Step 2: CBT for insomnia (CBT-I)
CBT-I is the first-line evidence-based psychotherapy for insomnia in the general population, recommended by both the American Academy of Sleep Medicine and the UK NICE. Its components include sleep restriction, stimulus control, cognitive restructuring of unhelpful sleep thoughts, and relaxation training. Studies in schizophrenia samples — including the work by Freeman and colleagues at Oxford — have found that CBT-I is feasible, well-tolerated, and effective for sleep symptoms in this group, with possible benefits for psychotic symptoms as well. See our dedicated piece on CBT-I in schizophrenia.
Step 3: Optimise the antipsychotic
Sometimes the simplest intervention is timing. Many sedating antipsychotics — quetiapine, olanzapine, clozapine — can be dosed in the evening to use the sedation as part of the sleep plan. Activating agents may need to be moved to morning. In some cases, a switch in antipsychotic is reasonable. None of this should be done unilaterally; talk to your prescriber.
Step 4: Treat contributors
Underlying issues that should be addressed:
- Sleep apnea — often missed, see sleep apnea and schizophrenia.
- Restless legs syndrome — common, often related to dopamine blockade.
- Substance use — alcohol fragments sleep, cannabis disrupts REM, caffeine and nicotine prolong sleep latency.
- Depression — frequently comorbid and a major driver of insomnia.
Step 5: Sleep medications, used carefully
If behavioural and CBT-I approaches and antipsychotic timing have not been enough, sleep medications may be appropriate. Choices include:
Melatonin
Generally well-tolerated. Most useful for circadian-rhythm-driven insomnia (delayed sleep phase) at low doses (0.3–3 mg) taken several hours before desired bedtime. Higher doses are not necessarily more effective. See melatonin in schizophrenia.
Trazodone
Low-dose trazodone is one of the most commonly prescribed off-label sleep aids in psychiatry. Potential side effects include morning sedation, dizziness, and rarely priapism in men.
Mirtazapine
Sometimes used at low doses for combined depression and insomnia, with the trade-off of weight gain and sedation. See mirtazapine augmentation.
Non-benzodiazepine "Z-drugs"
Zolpidem, zopiclone, and eszopiclone act on GABA receptors and can shorten sleep latency. They carry tolerance and dependence risk and are best used short term.
Doxepin
At very low doses (3–6 mg), doxepin is FDA-approved for sleep maintenance with a relatively favourable safety profile.
Newer agents — orexin antagonists
Suvorexant, lemborexant, and daridorexant block wake-promoting orexin signalling. Studied mostly in general insomnia populations; some data emerging in psychiatric populations.
Benzodiazepines
Generally avoided for chronic insomnia because of dependence, tolerance, fall risk, and cognitive effects, particularly in older adults. Short-term use during acute crises sometimes appropriate under careful supervision.
Sleep deteriorates over multiple nights along with returning voices, paranoia, or disorganisation — these together can signal an oncoming relapse. Contact your prescriber rather than self-treating.
What to avoid
- Diphenhydramine (Benadryl) and other sedating antihistamines — anticholinergic effects worsen cognition and have been associated with longer-term cognitive risk.
- Alcohol as a sleep aid — fragments sleep and worsens apnea.
- Cannabis as a sleep aid — disrupts REM and can worsen psychotic symptoms.
Tracking what works
A simple sleep diary or a wearable tracker can help you and your prescriber see what is actually changing. Frida and similar apps can fold sleep tracking into a broader stability picture. Look for trends, not perfection.
Bottom line
Treating insomnia in schizophrenia takes patience and a layered approach. Start with behavioural foundations and CBT-I, optimise the antipsychotic, address contributors, and use medications selectively. The reward is better days, lower relapse risk, and a measurable boost to quality of life.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.